← Back to Guides

Guide

How does the layer model fit with other explanations of migraine?

Last updated April 28, 2026

Quick Answer

How does the layer model fit with other explanations of migraine?

The layer model isn't a competing mechanistic explanation to cortical spreading depression, CGRP signaling, or central sensitization. It operates at a different level of abstraction. Established models explain HOW an attack happens (the electrophysiology, the vasoactive peptides, the trigeminovascular cascade). The layer model explains WHEN attacks happen and WHY treatment-resistant patients fail standard care. Both are needed, and they fit together cleanly: layered physiological load determines threshold position; established mechanisms determine what happens once threshold is crossed.

If you have spent any time in migraine forums, neurologists' offices, or reading the literature, you have run into multiple competing-sounding explanations: cortical spreading depression, CGRP, central sensitization, hormonal withdrawal, genetics, hypothalamic activation, neuroinflammation. They cannot all be the "real" cause. Or can they?

They can, and they are. Each explains a different part of the system at a different level of abstraction. The layer model used by Migraine Detective is not a competitor to any of them. It is an integrating clinical framework that uses the established mechanisms as its building blocks while answering the question they don't address: why now, in this person, today.

Key insight

Established mechanisms (CSD, CGRP, central sensitization) explain HOW migraine attacks happen at the level of cells and circuits. The layer model explains WHEN attacks happen and WHY treatment-resistant patients fail standard care. Both are needed; neither replaces the other.

Established models

The seven established explanations and what each gets right

A brief intellectually honest survey of the major mechanistic and clinical models of migraine, what each explains well, and what each leaves unexplained.

Model 1

Cortical spreading depression (CSD): the dominant neurological model
A wave of neuronal depolarization followed by suppression spreads across the cortex at roughly 3 mm per minute. This is what causes the visual aura phenomena and is thought to initiate the pain cascade via trigeminal nerve activation. CSD is the most academically accepted explanation of the aura mechanism. What it explains well: aura, the specific visual phenomena (zigzag lines, scintillating scotoma), why triptans (which affect trigeminal pathways) work acutely. What it does not explain: why CSD gets triggered more easily in some people at some times than others. The layer model is downstream-compatible: layered load lowers the threshold for CSD to initiate. The two are not competing.

Model 2

Trigeminovascular activation: the CGRP model
CGRP (calcitonin gene-related peptide) is released from trigeminal nerve endings and causes vasodilation plus neurogenic inflammation around the meninges. This is the basis for the entire CGRP drug class (Aimovig, Ajovy, Emgality, Vyepti for prevention; Nurtec, Ubrelvy, Zavzpret for acute). What it explains well: the throbbing pain, the nausea, the photophobia. What it does not explain: why CGRP blockers fail for roughly 50 percent of patients, and why the same person has wildly different attack severity at different times. CGRP is one output of a nervous system that has crossed threshold; blocking CGRP downstream is treating the exhaust, not the engine.

Model 3

Central sensitization: the allodynia model
With repeated migraine attacks, the central nervous system becomes progressively sensitized. Pain pathways become easier to activate, thresholds drop, and eventually even light touch causes pain (cutaneous allodynia). This explains why chronic migraineurs have attacks with no obvious trigger. What it explains well: why migraines tend to get worse over time, why medication overuse headache happens, why allodynia develops in chronic patients, why stress alone can trigger an attack in long-standing migraine. What it does not explain well: why sensitization fluctuates, why some months are much better than others without medication changes. The layer model handles the fluctuation: sensitization is a baseline shift that compounds with the dynamic layer load.

Model 4

Hormonal / estrogen withdrawal model
Falling estrogen triggers migraine in susceptible women through changes in serotonin signaling, CGRP release, prostaglandin levels, and (per recent literature) the simultaneous late-luteal progesterone drop that destabilizes mast cells and reduces DAO activity. The mechanism is well-documented across menstrual migraine, perimenopause, and combined hormonal contraception use. What it explains well: the menstrual migraine pattern (ICHD-3 day -2 to +3 window), perimenopausal worsening, post-pill migraine. What it does not explain: why not all women with estrogen fluctuations get migraines, and why the same hormonal drop causes a migraine one cycle but not another. The hormonal model is one layer in the layer model, not a standalone explanation.

Model 5

Genetic / neurobiological predisposition model
Migraine has roughly 50 percent heritability. Specific gene variants matter: CACNA1A, ATP1A2, and SCN1A for familial hemiplegic migraine (a rare monogenic form), and many small-effect GWAS hits for common migraine that affect ion channels, neurotransmitter handling, and cortical excitability. Brain structure is measurably different in migraineurs (thicker cortex in sensory processing areas, different white matter patterns per VBM and DTI studies). What it explains well: why some people get migraines and others do not, and why treatment response varies between individuals. What it does not explain: why attacks are episodic rather than constant. If the brain is always genetically abnormal, why are you not always in an attack? The layer model answers that: genetics set the threshold ceiling; layered load determines threshold position day to day.

Model 6

Hypothalamic prodrome model
Newer research (Maniyar and Goadsby 2014; subsequent work) shows the hypothalamus activates in the prodrome phase, 24 to 48 hours before the headache. Prodromal symptoms (yawning, food cravings, mood changes, fatigue, sleep disruption) are all hypothalamic. This reframes migraine as a brain state that begins before pain, initiated centrally rather than peripherally. What it explains well: prodromal symptoms, why sleep disruption triggers attacks (hypothalamus regulates sleep), why stress is a trigger (HPA axis runs through the hypothalamus). What it does not explain: what dysregulates the hypothalamus in the first place, and why episodically. The hypothalamus is essentially the integrator of layered load. The layer model could be reframed as 'what loads the hypothalamus.'

Model 7

Immune / neuroinflammation model
Growing evidence links mast cell activation, microglial activation, and low-grade neuroinflammation to migraine. MCAS (mast cell activation syndrome) patients have dramatically elevated migraine rates. COVID-19 triggered new-onset migraine in many patients, presumably through neuroinflammatory mechanisms. What it explains well: why histamine, certain foods, and inflammatory events trigger attacks; why MCAS and migraine overlap so heavily; why some patients respond to anti-inflammatory or antihistamine interventions. What it does not explain on its own: the full mechanism connecting peripheral immune activation to central threshold lowering. Inflammatory load is explicitly one layer in the layer model; this model supports rather than competes.

The integration

How the layer model integrates all seven

Different levels of abstraction

CSD and CGRP describe the cellular and biochemical mechanism of an attack: what happens in neurons and around blood vessels once an attack initiates. The layer model describes the patient-level inputs that determine WHEN initiation happens. These are not the same thing. A neurologist explaining the CGRP cascade and a clinician asking 'what's loading your nervous system this week' are describing the same disease at different scales.

Static vs dynamic threshold

Genetics + central sensitization define a STATIC baseline threshold: the floor below which attacks are easy. The layer model adds the DYNAMIC component: how much load is currently stacked on top of that baseline at any moment. Hormonal swings, sleep debt, histamine intake, inflammation, vascular state, autonomic shifts. When dynamic load + baseline reduction crosses the threshold, an attack initiates via CSD / trigeminovascular cascade / hypothalamic dysregulation. The mechanisms are not in conflict; they operate at different timescales.

The hypothalamus as integrator

The hypothalamus is the organ that receives inputs from every layer: hormonal (gonadal axis), sleep (suprachiasmatic nucleus), stress (HPA axis), autonomic (sympathetic/parasympathetic balance), metabolic (energy state). The layer model is essentially a clinical description of what the hypothalamus is integrating. When the integrated load crosses threshold, the hypothalamus initiates the prodromal cascade that becomes a full attack hours later. This is why Maniyar and Goadsby's hypothalamic-prodrome research is so compatible with the layer-model framework.

Genetics as ceiling, layers as room to maneuver

If your genetic profile gives you a low threshold ceiling (your floor sits closer to attack initiation than the average person's), your room to maneuver is smaller. Lifestyle layers matter MORE for you, not less, because each unit of load gets you closer to threshold faster. This explains why two people with similar lifestyles have wildly different migraine experiences: same load, different ceilings. It also explains why some people respond beautifully to a single intervention (their dominant layer is single) while others need a multi-layer approach (multiple layers active).

Treatment-resistance is layer mismatch

Most treatment failures in migraine are not 'the drug doesn't work' failures. They are mismatches between the drug's mechanism (CGRP, serotonin, calcium channel, etc.) and the patient's dominant active layer (hormonal, histamine, vascular, autonomic). Triptans target serotonin and the trigeminovascular cascade; if your dominant driver is histamine load from late-luteal progesterone drop, triptans miss the layer that is actually generating attacks. This is why the 50 percent non-response rate to CGRP medications is not a failure of CGRP science. It is identification of a subgroup whose dominant layer is not CGRP-driven.

Bottom line

The layer model and the established mechanistic models answer different questions. Established models answer "how does an attack happen biologically?" The layer model answers "why now, why this person, and which intervention matches the active driver?" You need both to do good migraine care.

The honest positioning

What the layer model adds, and what it does not claim

Adds

A clinical framework for the WHEN question
Established mechanisms describe HOW. The layer model describes WHEN. Why does the same trigger cause an attack one day and not another? Because the threshold is dynamic and depends on layered load. This is the question patients actually live with, and it is the question standard mechanistic explanations leave unanswered.

Adds

An investigation methodology
The layer model is paired with a structured investigation approach: identify which layers are active in an individual patient via longitudinal data, generate testable hypotheses, address the dominant driver rather than the most-studied one. The methodology is the actual contribution. The threshold concept itself has existed in headache literature for decades.

Adds

A reframe for treatment-resistance
Treatment-resistant migraine is not a failure of medicine. It is usually a layer mismatch: the prescribed intervention does not match the patient's dominant active layer. The model gives clinicians and patients a vocabulary to reason about this directly rather than escalating within a mismatched mechanism class.

Does not claim

A new mechanism of attack initiation
The layer model does not propose new biology. It does not say CSD or CGRP signaling is wrong. It does not replace neurology. It does not invent new physiological mechanisms. It organizes existing mechanisms into a framework that maps to clinical decision-making.

Does not claim

To replace evidence-based medicine
Every claim in the model is built on published mechanism research. Hormonal modulation of mast cells and DAO: peer-reviewed. Sensitization via repeated attacks: peer-reviewed. Hypothalamic prodrome: peer-reviewed. The model integrates established science; it does not bypass it.

Does not claim

To work for everyone
Some patients have one dominant layer and respond to one intervention. The layer model does not add value for them; the standard mechanistic approach already works. The model adds value specifically for treatment-resistant cases where multiple layers are active and standard single-mechanism approaches have failed.

The neurologist conversation

Anticipating the pushback

A common reaction from clinicians familiar with migraine literature: "the threshold model is well-known. This is not new." That response is correct in part and worth engaging with directly.

The threshold concept has existed in migraine literature for decades. Lance and Goadsby's textbook, Olesen's writings, the entire neurology training curriculum touches on it. What is new is not the concept. What is new is:

New 1

Systematic application via longitudinal data
Most clinicians know about threshold conceptually but cannot apply it systematically because they do not have the longitudinal patient-side data needed to identify which layers are active. AI-assisted pattern analysis on continuous tracking changes that. The patient brings months of structured data to the conversation; the clinician can act on it.

New 2

An investigation methodology designed for the patient
Most migraine education tells patients about triggers but not about how to investigate their own pattern. The Migraine Detective Method gives patients a structured approach (gather clues, analyze patterns, test hypotheses) borrowed from how investigators actually work. This is patient-facing methodology that did not exist as a coherent product before.

New 3

A clinical reframe for treatment-resistance
The framing of treatment-resistance as 'layer mismatch' rather than 'drug failure' is a useful clinical reframe even when the underlying biology is unchanged. It changes what comes next: instead of 'try a stronger version of the same drug,' the next step becomes 'identify which layer is now dominant and match the intervention.'

Why this matters

Most migraine patients are taught about triggers but not about why triggers are conditional. They are taught about medications but not about why some work and others don't. They are taught the disease is complex but not how to think about that complexity in their own case. The layer model is not new biology, but it is a new way of organizing what is already known so that an individual person can investigate their own migraine instead of just managing it. The established mechanistic models (CSD, CGRP, central sensitization, hormonal, genetic, hypothalamic, neuroinflammatory) are all true and all useful. The layer model uses them as building blocks rather than competing with any of them.

Free checklist

Get the layer investigation checklist

One email. Four migraine layers most workups miss (hormonal, histamine, vascular, supplement form), with a pattern clue and first test for each.

Frequently asked questions

Is the layer model a competing theory to cortical spreading depression or CGRP?
No. Cortical spreading depression (CSD) and trigeminovascular CGRP signaling explain the electrophysiology and biochemistry of an attack: HOW pain is generated. The layer model explains WHEN attacks happen and WHY they happen now and not yesterday. They operate at different levels of abstraction. The layer model is downstream-compatible with CSD and CGRP: layered physiological load determines threshold position; established mechanisms determine what happens once threshold is crossed.
If migraine is genetic, why does the layer model matter?
Migraine has roughly 50 percent heritability, and specific gene variants (CACNA1A, ATP1A2, SCN1A in familial hemiplegic migraine; many smaller GWAS hits in common migraine) affect ion channels, neurotransmitter handling, and cortical structure. Genetics set the ceiling on your threshold: how low your baseline can go. But genetics do not explain why migraine is episodic rather than constant. If your brain is always genetically migraine-prone, why are you not always in an attack? The layer model answers that question: cumulative load from hormonal, vascular, histamine, sleep, and inflammatory factors crosses a dynamic threshold. Genetics define the floor; layers define what's stacked on top.
Why do CGRP medications work for some people but not others?
CGRP (calcitonin gene-related peptide) is one important downstream signal in the trigeminovascular cascade, and blocking it is genuinely useful for the roughly 50 percent of patients whose migraines are CGRP-dominant. The other 50 percent fail CGRP medications because their dominant driver is hormonal, histamine, vascular, or autonomic. CGRP blockade addresses one output of a nervous system that has crossed threshold. If the cause of crossing the threshold is somewhere else, blocking CGRP downstream is treating the exhaust, not the engine. The layer model helps identify which mechanism is driving an individual patient's attacks.
Where does central sensitization fit in?
Central sensitization is the structural lowering of the migraine threshold caused by attack history. With repeated attacks, pain pathways become easier to activate, the threshold drops, and eventually even light touch causes pain (allodynia). The layer model accommodates this directly: sensitization is a baseline shift that compounds dynamic layer load. A sensitized brain has less headroom; the same hormonal swing or histamine spike that was tolerable in year 1 produces a worse attack in year 5. This is why breaking medication overuse cycles and reducing attack frequency are upstream interventions, not just symptom management.
What about the hypothalamic prodrome model?
Newer research from the 2010s onward (Maniyar and Goadsby's fMRI studies, among others) shows the hypothalamus activates 24 to 48 hours before the headache phase. Yawning, food cravings, mood changes, fatigue, and sleep disruption in the prodrome are all hypothalamic symptoms. This reframes migraine as a brain state that begins before pain. The hypothalamus is essentially the integrator: it aggregates hormonal signals, sleep pressure, stress hormones, and inflammatory load, and when its set point shifts, the attack cascade initiates. The layer model could be reframed as 'what loads the hypothalamus.' The two are complementary descriptions of the same system at different levels.
Does the immune / neuroinflammation model conflict with the layer model?
No, it supports it. Growing evidence links mast cell activation, microglial activation, and low-grade neuroinflammation to migraine. MCAS (mast cell activation syndrome) patients have dramatically elevated migraine rates. COVID-19 triggered new-onset migraine in many patients through neuroinflammatory mechanisms. Inflammatory load is explicitly one of the layers in the layer model; the immune mechanism is one of the things being measured.
How does the hormonal model fit?
Hormonal mechanisms (estrogen withdrawal, the late-luteal progesterone drop, perimenopausal volatility) are well-documented and explain menstrual migraine, perimenopause worsening, and combined hormonal contraception effects. But they do not explain why two women with similar hormonal profiles have different migraine experiences, or why the same hormonal drop causes a migraine one cycle but not another. The hormonal layer is one of several in the layer model, not a standalone explanation.
What does the layer model add that established models don't?
Established models explain mechanism: HOW attacks happen at the level of cells, signals, and circuits. They are accurate and necessary. What they don't address well is WHY ATTACKS HAPPEN WHEN THEY DO and WHY TREATMENT-RESISTANT PATIENTS FAIL STANDARD CARE. The layer model is a clinical framework that operates at a different level of abstraction: it organizes the multi-system inputs (hormonal, vascular, histamine, sensitization, inflammation, sleep, autonomic) that determine threshold position on any given day. The investigation methodology (track which layers are active in an individual patient, generate testable hypotheses, address the dominant driver rather than the most-studied one) is the new contribution. The threshold concept itself has existed in headache literature for decades.

If this feels frustrating, that's normal. Most people with migraines aren't missing discipline or willpower - they're dealing with overlapping systems that shift over time and don't show up on standard tests.

Ready to apply this to your own pattern?

The layer model is most useful when applied to a specific case. You can start with a quick assessment to see which layer is dominant for you, or talk it through with the Detective AI.

Educational pattern exploration, not medical advice.

Already have test results?

If you've accumulated years of normal tests but still have migraines, those records may contain patterns that haven't been examined together.

→ Review My Test Results

Related reading

This is educational content, not medical advice. Always consult a qualified clinician.